ERICA GARCIA: Open Payments
NPI 1063817849 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,004 in 182 payments from 18 companies in 2025. Trend: 2023 $1,686 · 2024 $2,286 · 2025 $4,004
Food & beverage: $3,970Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $725 |
| GENZYME CORPORATION | 21 | $548 |
| ARS Pharmaceuticals Operations, Inc. | 15 | $298 |
| Regeneron Healthcare Solutions, Inc. | 9 | $292 |
| GlaxoSmithKline, LLC. | 20 | $280 |
| SANOFI-AVENTIS U.S. LLC | 11 | $278 |
| CSL Behring | 7 | $212 |
| Ionis Pharmaceuticals, Inc. | 9 | $201 |
| Amgen Inc. | 16 | $181 |
| Galderma Laboratories, L.P. | 10 | $180 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, NEFFY, XOLAIR, NEMLUVIO, TRELEGY ELLIPTA, Hizentra.
Industry payments across TX — which companies pay providers there.
